Skip to main content
. 2017 May 2;23:2096–2103. doi: 10.12659/MSM.901183

Figure 4.

Figure 4

CPS-C enhances oxaliplatin-induced apoptosis in ESCC cell lines TE-1 and TE-2. *, ** Statistically significant difference (P<0.01) between the CPS-C + oxaliplatin treatment group and the oxaliplatin treatment group in TE-1 and TE-2, respectively.